Real-time enrollment status for this newly diagnosed glioblastoma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 10:21 PM UTC
| NCT Number | NCT05380349 |
| Recruiting Status | Recruiting |
| Condition | Newly Diagnosed Glioblastoma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 10 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Swedish Medical Center |
| Last Updated on CT.gov | May 16, 2025 (May 16, 2025) |
As of July 16, 2026: Clinical trial NCT05380349 is currently recruiting participants. This early_phase1 study for newly diagnosed glioblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Swedish Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05380349 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05380349 was last updated May 16, 2025 (May 16, 2025). HelloStudys verifies this status automatically.